InvestigationalInvestigational

Pemvidutide

Also known as:ALT-801

Class
Investigational
Route
SC injection
Frequency
Once weekly in trials
GLP-1 relevance
Yes

How it works

Balanced GLP-1/glucagon dual receptor agonist

Approved & studied uses

MASH / obesity pipeline

Regulatory status

Investigational

Safety notes

No approved dosing.

Sources

Educational reference only. This page does not provide diagnosis, dosing, titration or treatment recommendations. Peptimize does not recommend or adjust any medication schedule - that is between you and your prescriber.